Request for Covid-19 Impact Assessment of this Report
MARKET DYNAMICS
MARKET DRIVERS:
--> Ease of sharing, storing and reading images.
--> Increase in productivity due to the same interface across all imaging modalities.
--> Higher flexibility, since digital images can also be accessed on mobile devices.
--> Rising diagnostic check-ups.
MARKET RESTRAINTS:
--> High cost of the software, since they are licensed products and not open-source.
--> Dearth of skilled professionals who are trained enough to handle such software.
--> Growing hacking related risks associated with the use of digital storage.
MARKET SEGMENTATION:
The global imaging analysis software market can be segmented on the basis of:
1. Software Type: Integrated software and standalone software. Due to the growing adoption of imaging systems, the integrated software segment is expected to account for a larger market value.
2. Imaging Type: 2D imaging, 3D imaging, and 4D imaging. While 2D is the traditional imaging type, the 3D and 4D imaging types capture a true three-dimensional image.
3. Imaging modality:Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI),X-Ray, Computed Tomography (CT), and Ultrasound. These are some of the various types of equipment or probes used for imaging.
4. Application:Cardiology, Orthopedic, Oncology, Neurology, Nephrology, Dental, Gynecology, and Others branches of modern medicine.
5. End User:Hospitals, Clinics, Research and academic institutes, Diagnostic centers, and Ambulatory Surgical Centers.
GEOGRAPHICAL ANALYSIS:
On the basis of region, the global medical image analysis software market can be segmented into North America, Europe, Asia and Rest of the World.
--> North America: This region is expected to dominate the market in the given forecast period. An aging population, favourable reimbursement policies, and technological advancements are driving this market in North America.
--> Europe: Expected to follow North America in terms of market value as it is doing presently.
--> Asia: The Asian market is expected to experience a higher growth rate in the forecast period especially due to increasing government action towards healthcare infrastructure modernization, ongoing research activities and a growing portfolio of imaging techniques.
KEY PLAYERS:
--> Koninklijke Philips N.V. (The Netherlands).
--> General Electric Company (U.S.).
--> Siemens AG (Germany).
--> Agfa-Gevaert N.V. (Belgium).
--> Carestream Health, Inc. (U.S.).
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...